Dan Gui, MD, PhD

Dan is a clinical fellow in medical oncology and postdoctoral fellow in the Aguirre and Van Allen Labs, specializing in gastrointestinal oncology and pancreatic cancer research. His research focuses on unraveling the mechanisms behind treatment resistance in pancreatic cancer. As part of his work at Dana-Farber Cancer Institute, he has identified a novel secretory-epithelial program linked to treatment resistance.
 
Dan earned his PhD from the Massachusetts Institute of Technology (MIT), where he trained with Matt Vander Heiden, working on cancer metabolism. He completed his MD at Harvard University in 2019, followed by residency at Brigham and Women's Hospital. Outside of work, he enjoys spending time with his wife and children.